Tissue-resident memory CD8<sup>+</sup> T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31562311.
- Also identified by DOI 10.1038/s41467-019-12319-x and PMC identifier 6765014.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Tissue-resident memory CD8<sup>+</sup> T (Trm) cells mediate potent local innate and adaptive immune responses and play a central role against solid tumors. However, whether Trm cells cross-talk with dendritic cells (DCs) to support anti-tumor immunity remains unclear. Here we show that antigen-specific activation of skin Trm cells leads to maturation and migration to draining lymph nodes of cross-presenting dermal DCs. Tumor rejection mediated by Trm cells triggers the spread of cytotoxic CD8<sup>+</sup> T cell responses against tumor-derived neo- and self-antigens via dermal DCs. These responses suppress the growth of intradermal tumors and disseminated melanoma lacking the Trm cell-targeted epitope. Moreover, analysis of RNA sequencing data from human melanoma tumors reveals that enrichment of a Trm cell gene signature associates with DC activation and improved survival. This work unveils the ability of Trm cells to amplify the breath of cytotoxic CD8<sup>+</sup> T cell responses through DCs, thereby strengthening anti-tumor immunity.
Medical subject headings
- CD8-Positive T-Lymphocytes
- Dendritic Cells
- Immunologic Memory
- Melanoma
- Skin